NeoGenomics, Inc. is a leading provider of cancer-focused diagnostics and testing services, operating an extensive network of laboratories across the United States, Europe, and Asia. Headquartered in Fort Myers, Florida, the company specializes in molecular and genomic testing, aiming to improve patient outcomes through innovative diagnostic solutions. With a commitment to advancing cancer care, NeoGenomics leverages cutting-edge technology and a robust portfolio of tests to support healthcare providers and patients in making informed treatment decisions.
Click "Analyze" to generate stock analysis
NEO Price Trend and Signals
NEO Option Volumes & Open Interests (aggregated)
NEO Put Call Ratios and IV (aggregated)
NEO Financials
2025-10-28Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-24Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-20Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.